Limitations of randomised controlled trials as evidence of drug safety

被引：4
作者：
Thynne, Tilenka R. J. [1 ,2 ]
Gabb, Genevieve M. [1 ,2 ,3 ,4 ]
机构：
[1] Flinders Med Ctr, Div Med Cardiac & Crit Care, Bedford Pk, SA, Australia
[2] Flinders Univ S Australia, Coll Med & Publ Hlth, Bedford Pk, SA, Australia
[3] Royal Adelaide Hosp, Acute & Urgent Care, Adelaide, SA, Australia
[4] Univ Adelaide, Sch Med, Discipline Med, Fac Hlth Sci, Adelaide, SA, Australia
来源：
AUSTRALIAN PRESCRIBER | 2023年 / 46卷 / 02期
关键词：
adverse drug reaction reporting; clinical trials; drug safety; ethnic and racial minorities; ANGIOEDEMA;
D O I：
10.18773/austprescr.2023.005
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：22 / 23
页数：2
相关论文
共 9 条
[1]   Vancomycin Infusion Reaction - Moving beyond "Red Man Syndrome" [J].
Alvarez-Arango, Santiago ;
Ogunwole, S. Michelle ;
Sequist, Thomas D. ;
Burk, Caitlin M. ;
Blumenthal, Kimberly G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (14) :1283-1286
[2]   Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart Disease [J].
Bourgeois, Florence T. ;
Orenstein, Liat ;
Ballakur, Sarita ;
Mandl, Kenneth D. ;
Ioannidis, John P. A. .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 (11) :2354-2361
[3]   Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. [J].
Exner, DV ;
Dries, DL ;
Domanski, MJ ;
Cohn, JN .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (18) :1351-1357
[4]   Epidemiological study of angioedema and ACE inhibitors [J].
Gabb, GM ;
Ryan, P ;
Wing, LMH ;
Hutchinson, KA .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1996, 26 (06) :777-782
[5]   Participation of Women and Older Participants in Randomized Clinical Trials of Lipid-Lowering Therapies A Systematic Review [J].
Khan, Safi U. ;
Khan, Muhammad Zia ;
Subramanian, Charumathi Raghu ;
Riaz, Haris ;
Khan, Muhammad U. ;
Lone, Ahmad Naeem ;
Khan, Muhammad Shahzeb ;
Benson, Eve-Marie ;
Alkhouli, Mohamad ;
Blaha, Michael J. ;
Blumenthal, Roger S. ;
Gulati, Martha ;
Michos, Erin D. .
JAMA NETWORK OPEN, 2020, 3 (05)
[6]   Reporting adverse drug events to the Therapeutic Goods Administration [J].
Martin, Jennifer H. ;
Lucas, Catherine .
AUSTRALIAN PRESCRIBER, 2021, 44 (01) :2-3
[7]   SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A South Australian Clinical Case Series and Australian Spontaneous Adverse Event Notifications [J].
Meyer, Emily J. ;
Gabb, Genevieve ;
Jesudason, David .
DIABETES CARE, 2018, 41 (04) :E47-E49
[8]   Angiotensin-converting enzyme inhibitors and angioedema - Estimating the risk [J].
Weber, Michael A. ;
Messerli, Franz H. .
HYPERTENSION, 2008, 51 (06) :1465-1467
[9]   Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes [J].
Fischereder, Michael ;
Schoenermarck, Ulf .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (11) :1092-1093
1